MCB insider plans sale of 10,000 common shares

MCB filed a notice for a planned sale of 10,000 shares of common stock through J.P.

Rhea-AI Filing Summary

MCB filed a notice for a planned sale of 10,000 shares of common stock through J.P. Morgan Securities LLC, with the shares listed on the NYSE and an intended sale date of August 10, 2026. The shares to be sold were originally received as board-of-directors compensation in several grants, including 5,000 shares on June 24, 2013, 3,688 shares on December 23, 2013, 812 shares on February 18, 2017, and 500 shares on February 24, 2017. Recent activity also shows the Robert C Patent Declaration of Trust selling 5,000 shares on June 4, 2026 and 10,000 shares on June 12, 2026, with reported sale amounts of 451,043 and 964,057, respectively.

Key Figures

Planned shares to be sold: 10,000 shares Trust sale on June 4, 2026: 5,000 shares; 451,043 Trust sale on June 12, 2026: 10,000 shares; 964,057 +4 more

7 metrics

Planned shares to be sold 10,000 shares Common stock planned for sale on August 10, 2026 via J.P. Morgan Securities LLC

Trust sale on June 4, 2026 5,000 shares; 451,043 Robert C Patent Declaration of Trust sale of common shares

Trust sale on June 12, 2026 10,000 shares; 964,057 Robert C Patent Declaration of Trust sale of common shares

Board compensation grant 5,000 shares Common stock received as BOD member on June 24, 2013

Board compensation grant 3,688 shares Common stock received as BOD member on December 23, 2013

Board compensation grant 812 shares Common stock received as BOD member on February 18, 2017

Board compensation grant 500 shares Common stock received as BOD member on February 24, 2017

Key Terms

Securities To Be Sold, Securities Sold During The Past 3 Months, Declaration of Trust

3 terms

Securities To Be Sold regulatory

"144: Securities To Be Sold"

Securities Sold During The Past 3 Months regulatory

"144: Securities Sold During The Past 3 Months"

Declaration of Trust financial

"The Robert C Patent Declaration of Trust 99 Park Avenue"

A declaration of trust is a legal document that spells out who holds assets on behalf of others, what duties the holder has, and how income or profits are shared among beneficiaries. For investors it matters because it clarifies who controls the asset, how returns and losses will be allocated, and what rules govern distributions—think of it like a written instruction that tells a custodian how to manage and split the proceeds so investors know their rights and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What share sale is disclosed for MCB in this Form 144 filing?

The filing discloses a planned sale of 10,000 shares of MCB common stock through J.P. Morgan Securities LLC, with an intended sale date of August 10, 2026 on the NYSE.

How were the MCB shares being sold originally acquired?

The shares were originally received as board-of-directors compensation in multiple grants, including 5,000 shares on June 24, 2013, 3,688 on December 23, 2013, 812 on February 18, 2017, and 500 on February 24, 2017.

Which broker is handling the proposed MCB share sale?

The planned sale of 10,000 MCB common shares is to be handled by J.P. Morgan Securities LLC, located at 270 Park Avenue, 10th Floor, New York, NY 10017.

What recent MCB share sales are reported for the Robert C Patent Declaration of Trust?

The Robert C Patent Declaration of Trust sold 5,000 MCB shares on June 4, 2026 and 10,000 shares on June 12, 2026, with reported sale amounts of 451,043 and 964,057, respectively.

On which exchange are the MCB shares involved in the Form 144 listed?

The common stock covered by this Form 144 notice is listed on the NYSE, as indicated in the section describing the 10,000-share proposed sale through J.P. Morgan Securities LLC.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/10/2026 - 05:38 PM Accepted by SEC EDGAR 08/10/2026 - 05:37 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001008343
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Metropolitan Bank Holding Corp
SEC File Number	001-38282
Address of Issuer	99 Park Avenue New York NEW YORK 10016
Phone	212-659-0600
Name of Person for Whose Account the Securities are To Be Sold	ROBERT C PATENT
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	J.P. Morgan Securities LLC 270 Park Avenue, 10th Floor New York NY 10017	10000	928600	12394797	08/10/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/18/2017	Received as BOD member	Issuer			812	02/18/2017	Compensation
Common Stock	06/24/2013	Received as BOD member	Issuer			5000	06/24/2013	Compensation
Common Stock	02/24/2017	Received as BOD member	Issuer			500	02/24/2017	Compensation
Common Stock	12/23/2013	Received as BOD member	Issuer			3688	12/23/2013	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
The Robert C Patent Declaration of Trust 99 Park Avenue New York NY 10016	Common	06/04/2026	5000	451043
The Robert C Patent Declaration of Trust 99 Park Avenue New York NY 10016	Common	06/12/2026	10000	964057

144: Remarks and Signature

Remarks	The shares filed today will be sold by The Robert C Patent Declaration of Trust, Robert C. Patent as Trustee
Date of Notice	08/10/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Robert C . Patent.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)